| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/11/2004 | US20040049813 Provides an alternative to the production of more expensive oils and to the chemical modification of oil to provide specific functional qualities and health attributes; useful in the manufacture of margarine and spread products |
| 03/11/2004 | US20040049812 Methods of achieving expression in plants without damaging the plant cell, the protein can be recovered without contamination by other proteases, and can be expressed at levels for commercial production of the enzyme |
| 03/11/2004 | US20040049811 Used in transgenic plants to promote high levels of expression of foreign and endogenous genes in developing seeds to affect seed lipid metabolism, protein or carbohydrate composition and accumulation, or seed development |
| 03/11/2004 | US20040049810 Maize gene dull1 (du1) is a determinant of the structure of endosperm starch |
| 03/11/2004 | US20040049809 Pear genes codifying for beta-galactosidase,pectin methylesterse, polygalacturonase, expansins and their use |
| 03/11/2004 | US20040049808 Methods of imparting resistance to insects and fungi, regulating the fiber cellulose content |
| 03/11/2004 | US20040049806 Nucleic acid encoding a plant very long chain fatty acid biosynthetic enzyme |
| 03/11/2004 | US20040049805 Plant promoters with an expression specificity for plant seeds; used as food, feed or seed, pharmaceuticals, fine chemicals or as industrial feedstock |
| 03/11/2004 | US20040049804 Maize defense-inducible genes and their use |
| 03/11/2004 | US20040049803 Metallothionein (MTI) and glutamine synthatase (GS) promoters capable of promoting the senescence-associated expression of nucleic acid coding sequences |
| 03/11/2004 | US20040049802 Method for modifying lignin composition and increasing in vivo digestibility of forages |
| 03/11/2004 | US20040049799 Method for screening agents capable of treating obesity |
| 03/11/2004 | US20040049249 Light activated gene transduction for cell targeted gene delivery in the spinal column |
| 03/11/2004 | US20040049037 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/11/2004 | US20040049025 Recombinant viral nucleic acids |
| 03/11/2004 | US20040049023 Useful in the study of vascular smooth muscle cell proliferation and in the treatment of blood vessel diseases that result from excessive smooth muscle cell proliferation, particularly after balloon angioplasty |
| 03/11/2004 | US20040049022 Single or multiple target anti-sense oligonucleotides (STA or MTA oligos) of low or no adenosine content for respiratory disease-relevant genes; effective in the prophylaxis and treatment of respiratory diseases and conditions |
| 03/11/2004 | US20040049021 Compositions and mehtods for treatment of Hepatitis C virus-associated diseases |
| 03/11/2004 | US20040049017 A protein complex which includes a growth factor, growth factor binding protein and vitronectin; for treating cancers, psoriasis, atherosclerosis and wounds prone to hypertrophic scarring |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049015 Antibodies specific to human prostacyclin synthase |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040049008 Templated molecules and methods for using such molecules |
| 03/11/2004 | US20040048826 Oligonucleotides containing 2'-0-modified purines |
| 03/11/2004 | US20040048825 Oligonucleotides, specifically hybridizable with nucleic acids encoding CREB; treatment of hyperproliferative disorder such as cancer and diseases caused by aberrant apoptosis. |
| 03/11/2004 | US20040048824 Antisense modulation of fibroblast growth factor receptor 3 expression |
| 03/11/2004 | US20040048820 Prevention or therapy of cardiovascular complications |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048800 Use of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 03/11/2004 | US20040048787 Lyophilizable and enhanced compacted nucleic acids |
| 03/11/2004 | US20040048781 Introducing into phagocytic cells that are in contact with immune complexes an inhibitor of a kinase endogenous to said cells associated with an Fc receptor present at the membrane of said cells |
| 03/11/2004 | US20040048384 Method and device for collecting and stabilizing a biological sample |
| 03/11/2004 | US20040048383 Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex |
| 03/11/2004 | US20040048382 Nucleic acid fragments encoding proteins involved in hemicellulose production in plants and seeds |
| 03/11/2004 | US20040048381 Vector |
| 03/11/2004 | US20040048380 Engineering of biological vectors for applications in the field of gene therapy |
| 03/11/2004 | US20040048379 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution |
| 03/11/2004 | US20040048378 Genetic manipulation of homologous recombination in meiosis and mitosis. |
| 03/11/2004 | US20040048376 Methods for modulating splicing and/or alternative splicing, and for identifying alternatively spliced units in genes |
| 03/11/2004 | US20040048374 Obtained by transferring a cell proliferation factor gene located between a pair of site-specific recombination sequences into a mammalian liver cell |
| 03/11/2004 | US20040048373 Production and long-term in vitro culture of these cell populations, and the use of neuroblasts in the treatment of various neuronal disorders as well as the identification of compositions which affect neuroblasts |
| 03/11/2004 | US20040048372 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048352 Immortal avian cells |
| 03/11/2004 | US20040048351 Alpha-amylase mutants |
| 03/11/2004 | US20040048349 Human orthologues of Wart |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048334 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/11/2004 | US20040048333 Membrane/fusion proteins; PRO polypeptides; immunoglobulins; solid phase synthesis; for modulating uptake of glucose by skeletal muscle cells |
| 03/11/2004 | US20040048331 For detection of mammalian tumors; for production of Lewis Y antigens; tumor associated antigens; immunoassay; rep genes/proteins; fusion proteins |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048314 Novel physiologically active peptide and use thereof |
| 03/11/2004 | US20040048308 Thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 03/11/2004 | US20040048307 Cell growth differentiation factors; for detecting increased muscle mass in food animals; kits |
| 03/11/2004 | US20040048298 An endogenous nucleic acid fragment of the retroviral type, integrated into the DNA of the human genome |
| 03/11/2004 | US20040048296 Human tumor necrosis factor TR20 and methods based thereon |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048293 Useful for obtaining tumour-selective gene expression in tumours having a mutated beta -catenin pathway; used to express genes encoding therapeutic proteins in colorectal cancer cells |
| 03/11/2004 | US20040048292 Used in analysis of differences in nucleic acid sequences; useful in Rolling Circle Amplification (RCA) reactions by increasing the specificity of discrimination between alleles |
| 03/11/2004 | US20040048289 A protein specific to a magnetic particle membrane, DNA which encodes the protein and their uses |
| 03/11/2004 | US20040048288 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase |
| 03/11/2004 | US20040048286 Can be used to diagnose and/or treat cardiovascular conditions including cardiac hypertrophy, myocardial infarction, stroke, arteriosclerosis, and heart failure |
| 03/11/2004 | US20040048282 Used in preventing, ameliorating, or correcting dysfunctions or diseases including diabetes, cancer, cardiovascular diseases, and peripheral and central nervous system disorders |
| 03/11/2004 | US20040048280 A polynucleotide that includes an endothelial specific enhancer element |
| 03/11/2004 | US20040048279 Effect of a substance on the organism or the cell culture is concluded by comparison with data of the methylation states of other samples and/or compared with other substances from a toxicological point of view |
| 03/11/2004 | US20040048277 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 03/11/2004 | US20040048275 Materials and methods relating to nucleic acid amplification and profiling |
| 03/11/2004 | US20040048273 Regulation of human secretin receptor-like gpcr |
| 03/11/2004 | US20040048272 Dendritically amplified detection method |
| 03/11/2004 | US20040048270 Through nested polymerase chain reaction in a combined liquid-phase/solid-phase-DNA-microarray system |
| 03/11/2004 | US20040048268 Method for massive directed mutagenesis |
| 03/11/2004 | US20040048267 Novel calpastatin (CAST) alleles |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048265 Obesity associated biallelic marker maps |
| 03/11/2004 | US20040048263 Novel g protein-coupled receptor protein and dna thereof |
| 03/11/2004 | US20040048260 Transfection of nucleic acid |
| 03/11/2004 | US20040048259 Testing of an organism and correlating the results with a unique marker (single nucleotide polymorphism or short tandem repeats)that identifies the sample; probes attached to beads which are associated with a chemical or physical |
| 03/11/2004 | US20040048256 Isolated polypeptide of given sequence; use in screening for identifying therapeutic antibodies and drugs |
| 03/11/2004 | US20040048254 Isolated nucleic acid of given sequence; oligomer which hybridizes to a chemically pretreated DNA; detecting the cytosine methylation state |
| 03/11/2004 | US20040048251 Synthesizing nucleic acid, contacting with a alkylamine, loading mixture onto media and applying a purification gradient using a suitable elution buffer |
| 03/11/2004 | US20040048246 Oligonucleotide for detection of HIV-1 and detection method |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040048237 Mammalian prion proteins and transgenic mice expressing them |
| 03/11/2004 | US20040047923 Infiltrating with a buffer solution; vacuum environment; centrifuging and concentrating |
| 03/11/2004 | US20040047883 For producing drug for stimulating the immune defences of the organism towards viral, parasitic or bacterial infections or cancerous antigens |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047877 Immunodominant human T-cell epitopes of hepatitis C virus |
| 03/11/2004 | US20040047875 For use in diagnosis, prophylaxis and therapy |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047857 Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047847 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047842 Monascus purpureus mutants and their use in preparing fermentation products having blood pressure lowering activity |